Answers are grounded in this paper and cite their sources.
Diagnostic anchoring, the tendency to maintain an initial diagnosis without adequate reassessment, is a well-recognized contributor to persistent misdiagnosis in psychiatry. In adults with unrecognized attention-deficit/hyperactivity disorder (ADHD), overlapping features such as emotional dysregulation, impulsivity, and behavioral instability may lead to misclassification as bipolar II disorder. Once assigned, this diagnosis may persist across providers and treatment settings without sufficient re-evaluation, resulting in inappropriate pharmacologic treatment, delayed identification of ADHD, and ongoing functional impairment. A woman in her late 40 s with a longstanding diagnosis of bipolar II disorder, assigned in her mid-20 s following a hypomanic episode during antidepressant treatment, presented after dozens of medication trials across multiple providers without sustained remission. Despite continued treatment within the bipolar II diagnostic framework, including a therapeutic trial of lithium, no clinical improvement was observed. Subsequent systematic reassessment, including developmental history, the Adult ADHD Self-Report Scale (ASRS; score 55), and the Diagnostic Interview for ADHD in Adults (DIVA 2.0), supported a diagnosis of ADHD. Mood stabilizer and antipsychotic therapy were discontinued and ADHD-targeted pharmacotherapy was initiated, after which rapid and sustained improvement in attention, emotional regulation, and overall functioning was observed. At 2-month follow-up, the Patient Health Questionnaire − 9 (PHQ-9) score had decreased from 24 to 6 and the Generalized Anxiety Disorder-7 (GAD-7) score from 17 to 3. This case illustrates how diagnostic anchoring can sustain misclassification of ADHD as bipolar II disorder across multiple providers and care settings over time. When treatment response is inconsistent with the established diagnostic framework, the diagnosis itself should be reconsidered rather than continuing pharmacologic adjustments within that framework. ADHD, particularly in women, may present with emotional dysregulation and behavioral features that overlap with mood disorders, increasing the risk of misdiagnosis and prolonged ineffective treatment.
No takes yet. Share an insight, caveat, or question.
Lisa George (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: